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Abstract
   The balance of lipid storage and utilization of lipids as a substrate of energy is maintained by complex biological 
signals. During nutrient-deﬁcient condition or excess physical activity, fatty acids are produced through lipolysis of lipid 
droplets by lipases and provide energy, or autophagy is induced. This review will summarize the regulators of lipolysis 
that maintain energy homeostasis and cellular signaling.
Introduction
 Body fuel selection of either glucose or fatty acids 
is altered in the complexities of dietary composition, 
age, disease, and various stresses to sustain energy 
homeostasis by using hormones and enzymes. Fatty 
acids are stored as triacylglycerol in adipose tissue 
constituted normally with amounts to 15‒20% of body 
weight. Food intake and energy balance play the most 
important role on controlling fat mass. According 
to WHO reports, obese individuals with BMI greater 
than or equal to 30 is about 13% of the world’s adult 
population (11% of men and 15% of women) in 2014. 
Obesity or overweight (BMI greater than or equal to 
25) is a major risk for cardiovascular diseases (mainly 
heart disease and stroke), diabetes, musculoskeletal 
disorders (especially osteoarthritis), and some cancers 
(endometrial, breast, and colon). Increasing incidences 
of both obesity and diabetes make the research on 
metabolism of adipose tissue progressive. 
 Mammals can physiologically control the balance 
between lipolysis and lipogenesis to maintain cellular 
energy homeostasis. The control of energy balance 
is critical to survive in various environment, such 
as starvation, cold temperature, and hypoxia. The 
typical example is that the amount of adipose tissue is 
inﬂuenced by surround environments. For an example 
during hibernation, being near 0.7 of the respiratory 
quotient (RQ; the ratio of the volume of carbon dioxide 
produced to the volume of oxygen consumed) indicates 
that fat is the major source for energy production to 
activate fatty acid metabolism during hibernation. The 
production of fatty acids from lipid stored in adipose 
tissue requires lipolytic enzymes. This review will focus 
on the activity of lipases that are biological adipose 
markers particular in lipolysis. In addition to lipases, it 
will describe the autophagy on adipose tissue and other 
tissues in the interaction to lipase. We summarize the 
mechanisms and regulators of lipase and autophagy 




1.  Enzymes related to Lipolysis
 Mammals store energy in white adipose tissues as 
triglycerides. During food intake, an excess of dietary 
fatty acids is esteriﬁed to triacylglycerol (TAG) and 
stored in cytosolic lipid droplet (LD) of adipocyte. During 
fasting or excess exercising, these TAG stored in LD are 
hydrolyzed in a process of lipolysis. Fatty acids degraded 
from TAG are delivered to peripheral tissues to produce 
ATP production by β-oxidation. Fatty acid is also 
essential substrates for the synthesis of lipids, such as 
membrane lipids and lipids involved in cellular signaling.
 Lipolysis is the biochemical pathway of the catabolism 
of triacylglycerol stored in cellular lipid deposits to 
produce free fatty acids. The mobilization of stored fats 
is mainly mediated by three kinds of lipolytic enzymes. 
First, triacylglycerol (TG) is selectively converted to 
diacylglycerol (DAG) by adipose triglyceride lipase 
(ATGL). Second, hormone-sensitive lipase (HSL) 
hydrolyzes DAG and TG to monoacylglycerol (MAG). 
Finally, monoacylglycerol lipase (MGL) cleaves MAG into 
glycerol and free fatty acids.
2.  Adipose triacylglyceride lipase (ATGL)
2.1.  The feature of ATGL
 Hormone-sensitive lipase (HSL) had been thought as 
a major lipolytic enzyme. However, HSL- deﬁcient mice 
did not show the increase of fat deposition and WAT 
mass and obesity.1) These ﬁndings suggested the present 
of another key enzyme of lipolysis. In 2004, ATGL, 
known as TAG hydrolases, desnutrin, and patatin-like 
phospholipase domain containing protein 2 (PNPLA2), 
was identiﬁed as a lipase which catalyzes the initial 
step in triglyceride hydrolysis.2-4) ATGL hydrolyzes TG 
to generate DAG and free fatty acids and also produces 
TAG and MAG from two DAG molecules in an acyl-CoA 
independent matter.4) On these reactions, ATGL is a 
rate-limiting enzyme in free fatty acid mobilization. HSL 
is rapidly and dramatically up-regulated by lipolytic 
hormones such as catecholamines through PKA 
phosphorylation of perilipin but ATGL is independent of 
PKA phosphorylation.
 ATGL is expressed at high levels in WAT and BAT 
and at low levels in testis, cardiac muscle, and skeletal 
muscle.2) ATGL (PNPLA2 and Pnpla2) encodes 504 and 
486 amino acid in human and mouse, respectively. ATGL 
contains an N-terminal patatin-like domain5) which was 
originally discovered in lipid acyl hydrolase of potato 
and other plants.3,6) The patatin domain in both the 
murine and the human enzyme contains a predicted 
esterase of the α/β hydrolase fold domain and can 
catalyze transacylation reactions independent of ATP 
and acyl-CoA. ATGL has Ser-47 and Asp-166 active sites 
which are both critical for TAG hydrolysis within the 
patatin domain in N-terminal.6) The C-terminal half of 
ATGL is expected to consist mostly of α-helical and loop 
regions. It is thought that a hydrophobic stretch (315-
360 amino acid) represents a binding region of lipid and 
eﬀects enzyme activity and LD binding.7,8)
2.2. The regulation factors of ATGL
 Having lipolytic enzyme activity on lipid droplets, 
ATGL is transferred to an adequate localization with 
its coactivator. To increase hydrolase activity, ATGL 
requires a coactivator protein called comparative 
gene identiﬁcation-58 (CGI-58, Abhd5) which is an 
α/β hydrolase fold enzyme. CGI-58 depends on PKA-
dependent phosphorylation of perilipin.9,10) Perilipin A 
(perilipin 1, lipid droplet-associated protein) is a lipid 
droplet scaﬀold and plays a key role in the regulation 
of hormone-stimulated lipolysis.11-13) Perilipin activation 
leads to perilipin phosphorylation and release of CGI-
58. Perilipin A, a predominant perilipin isoform in 
adipocytes, regulates ATGL-dependent lipolysis.14) Both 
Ser-492 and Ser-517 of perilipin are shown as the PKA 
phosphorylation site. These sites are necessary for 
release of CGI-58 and interaction between CGI-58 and 
ATGL by β-adrenergic stimulation of PKA.15)
 Gene expression of ATGL mRNA is elevated by 
peroxisome proliferator-activated receptor (PPAR) 
agonist, glucocorticoids,16) and fasting3,17). ATGL is 
a target for transcription by PPAR gamma.18) SIRT1 
upregulates expression of ATGL through PPAR gamma 
activity.19) Forkhead homeobox type O1 (FoxO1) plays 
an important role in the control of insulin-dependent 
expression of ATGL.20)
 ATGL mRNA is down-regulated by the treatment of 
insulin, isoproterenol, or TNF alpha and by the induction 
of G coupled pathways by forskolin and cholera toxin in 
3T3-L1 adipocytes.21,22). Activation of target of rapamycin 
complex 1 (TORC1) signaling inhibits expression of 
ATGL mRNA.23) Although isoproterenol and TNF alpha 
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reduce ATGL mRNA levels in adipocytes, they stimulate 
lipase activities to release fatty acids and glycerol. This 
diﬀerence between enzyme mRNA levels and activities 
is explained by extensive posttranslational regulation of 
ATGL and HSL. Therefore, cellular lipase mRNA levels 
cannot evaluate enzyme activities.
 The G0/G1 switch gene 2 (G0S2) induces cell cycle 
progression from the G0 to G1 phase of the cell cycle. 
G(0)/G(1) switch gene 2 (G0S2)-encoded protein binds 
directly to ATGL and inhibits ATGL-induced lipolysis.24) 
G0S2 mRNA is the highest level in WAT, BAT, and liver 
and its encoded protein directly interacts with patatin-
like domain of ATGL.24) This interaction is independent of 
presence of CGI-58.25) G0S2 mRNA level is upregulated 
by PPARγ agonists in adipocytes26), and by glucose 
in liver27). During adipogenesis, G0S2 mRNA level is 
upregulated in mice and human adipocyte cell.26) The 
level of G0S2 is decreased by chronic high fat feeding 
and increased by treatment of insulin in WAT. On the 
other hand, the expression of G0S2 is increased by 
fasting and by treatment of PPAR gamma agonist in 
hepatic cell.26)
 In this way, the regulation of ATGL is related to 
adipocyte diﬀerentiation with energy homeostasis.
2.3.  Functional linkage of ATGL
 Since the energy homeostasis is executed on the 
interaction between the metabolism of carbohydrates 
and fatty acids, ATGL is interacted with the metabolic 
factors of carbohydrates. ATGL binds pigment 
epithelium derived factor (PEDF) which is a 50 
kDa secreted glycoprotein and a regulator of TAG 
metabolism in liver. PEDK is reported that it has a role 
in promoting lipolysis through binding to ATGL in 
adipose tissue, muscle, and liver.28-30) PEDF is inversely 
regulated by insulin and hypoxia. PEDK is up-regulated 
in patients with type 2 diabetes. The up-regulation of 
PEDF induces insulin resistance in adipocytes.31) Fat-
speciﬁc protein 27 (FSP27) is a diﬀerentiation-regulated 
protein in adipocytes. FSP27 interacts with ATGL to 
inhibit lipolysis in human adipocytes.32) FSP27 regulates 
TG accumulation in ATGL dependent manner. Insulin 
acutely inhibits lipolysis. The decreased ATGL-derived 
FFAs leads to increase of glucose use, increase of glucose 
tolerance, and increase of insulin sensitivity.33) 
 The deﬁciency of ATGL and CGI-58 induces neutral lipid 
storage disease. While CGI-58 mutations are associated 
with Chanarin-Doefman syndrome (ichthyosis), disease 
characterized by the presence of a large number of 
cytosolic lipid droplet containing TG in various tissues 
such as the skin, liver, and leukocytes,34,35) mutations 
in the PNPLA2 were only reported with NLSD with 
myopathy (NLSDM).36) Also, NLSDM shows the severe 
defect in triglyceride degradation in ﬁbroblasts and the 
marked triglyceride storage in liver, muscles, and other 
visceral cells.36,37) In cardiomyopathy, the lipolysis of 
triglycerides by ATGL is an essential factor related to the 
generation of lipid ligands for PPAR activation in cardiac 
muscle.38)
3.  Hormone-sensitive lipase (HSL)
3.1.  The feature of HSL
 HSL is an intracellular neutral lipase and is a rate-
limiting lipase for the catabolism of DG. HSL-deﬁcient 
mice accumulate DGs in adipose tissue.39) Thus, it is 
known that HSL is more important to DG hydrolase 
than TG hydrolase. The phosphorylation state of HSL 
is changed to modulate free fatty acid secretion from 
adipocyte cells by hormones such as catecholamines, 
adrenocorticotropic hormone (ACTH), insulin, and 
natriuretic peptides.
 The expression of HSL mRNA is observed in both 
WAT and BAT. Low HSL expression is observed in many 
other tissues and cells such as steroidogenic cells, 
muscle, testis, pancreatic βcells, and macrophages.40,41) 
The characteristics of mRNA, protein size, and multiple 
potential transcription factor binding elements upstream 
of each exon of HSL are diﬀerent in each tissues.42,43) 
Therefore, it suggests the possibility of diﬀerential 
transcriptional regulation of HSL in diﬀerent tissues and 
under various physiological conditions.
 HSL has the 757-amino acid sequence. N-terminal 
region (1-300 amino acids) of HSL is a domain for 
interaction of HSL with adipocyte-binding protein 
(ALBP) and provides an additional mechanism for 
control of HSL activity.44) C-terminal domain (307-
768 amino acids) contains the α/β hydrolase fold 
which is a common structural fold in many lipases and 
esterases. Ser-424, Asp-693, and His-723 are reported 
as the catalytic domain.45) Also, it is reported that Asp-
703 and His-733 are related to lipase and esterase 
activity.46) Moreover, the third region (Ser-563, Ser-659, 
Ser-660, and Ser-600) was found as a regulatory module 
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of enzyme through phosphorylation and activation by 
PKA and extracellular signal regulated kinase (ERK).47-49) 
[Especially, Ser-563 is identiﬁed as markedly hydrophilic 
domain and a lipid-binding consensus site.50)]
3.2.  The regulation factors of HSL
 The phosphorylation state of HSL determines the 
activity of lipolytic enzyme. HSL is phosphorylated by 
cyclic AMP-dependent protein kinase (AMPK) and a 
ubiquitous serine/threonine protein kinase activated in 
response to environmental or nutritional stress factors 
which deplete intracellular ATP levels.51) The lipolysis 
by HSL is down-regulated by insulin, isoproterenol, 
and TNFα(which down-regulate ATGL in adipocyte21)) 
though cyclic AMP-mediated dephosphorylation.49) 
PKA activation promotes the translocation of HSL 
to lipid, which correlates with the magnitude of 
stimulated lipolysis in adipose tissue and muscle.52,53) 
Perilipin A interacts with HSL and stimulates lipolysis 
in adipocytes.14,54) It is reported that receptor-interacting 
protein 140 (RIP140) interacts with perilipin and controls 
lipolysis in adipocyte.55) HSL rapidly and speciﬁcally 
translocates to lipid droplets (LDs) containing perilipin. 
This translocation is partially dependent on perilipin 
phosphorylation.10) Although AMPK mediates HSL 
activity in adipose tissue56), AMPK is expected to be a 
more important mediator of HSL activity than in adipose 
tissue. AMPK decreases HSL activity increased by 
exercise through attenuating β-adrenergic stimulation 
in muscle.57) Extracellular signal-regulated kinase (ERK) 
enhances lipolysis activation of HSL by phosphorylating 
on Ser-600 amino acid.48) Glycogen synthase kinase-4 
and Ca2+/calmodulin-dependent kinase phosphorylate 
HSL at site 2 in vitro and in vivo.58,59)
3.3.  Functional linkage of HSL
 HSL interacts with adipocyte lipid-binding protein 
(ALBP) which is a member of the family of intracellular 
lipid binding protein.44) This interaction of HSL and ALBP 
suggests that traﬃcking of fatty acid generated during 
lipolysis is facilitated by ALBP.
 HSL interacts with steroidogenic acute regulatory 
protein (StAR). Steroidogenic acute regulatory protein 
(StAR) delivers cholesterol to the inner mitochondrial 
membrane. Steroid hormones are synthesized from 
cholesterol which is mostly supplied by the selective 
uptake of lipoprotein-derived cholesteryl esters. HSL 
-/- mice have profound eﬀects on cellular cholesterol 
homeostasis. HSL interacts the steroid hormone 
production on utilizing LDL-derived cholesteryl esters, 
as well as HDL-derived cholesteryl esters. Therefore, 
HSL facilitates cholesterol movement from lipid droplets 
to mitochondria for steroid hormone production.60) 
4.  Monoacylglycerol lipase (MGL)
4.1.  The function of MGL
 MGL is a rate-limiting enzyme for the break-down 
of MGs derived from, extracellular TG hydrolysis, 
intracellular TG hydrolysis and intracellular phospholipid 
hydrolysis. MGL degrades MG to glycerol and fatty 
acid. MSL is one of the superfamily of α/βhydrolase 
fold protein with GXSXG motif. N-terminal region has 
catalytic triads of Ser-122, Asp-239, and His-269.61)
4.2.  The regulation factors of MGL
 MGL mRNA is expressed in adipose tissue and various 
tissues, such as adrenal grand, ovary, heart, brain, lung, 
liver, skeletal muscle, kidney, and testis.61) It indicates 
that MGL is a widespread intracellular monoglyceride-
hydrolyzing enzyme.
4.3.  Functional linkage of MGL
 MSL inactivates endocannabinoid through hydrolysis 
of monoglyceride 2-arachidonoylglycerol (2-AG), one of 
activators of cannabinoid receptors in brain.62,63) These 
ﬁndings suggest that MGL has the possibility of the 
physiological role in endocannabioid metabolism related 
to appetite, pain sensation, and mood control.
5.  Autophagy
 During starvation, the autophagy induced is believed 
to be a critical factor for energy homeostasis because a 
role of autophagy is energy recycling. The inhibition of 
autophagy increases TG and LD in vitro and in vivo.64) 
Autophagy releases lipids and amino acid and uses 
as an energy source. The regulatory and functional 
mechanism of lipid release is similar to lipolysis. Thus, 
it is thought that the capability of lysosomes to degrade 
lipids may contribute to LD and TG breakdown in 
starvation.64) The studies using hepatocytes and liver 
have demonstrated that autophagy of LD is required for 
fasting-induced lipolysis in murine liver and cultured 
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hepatocytes.64) This study proposes the recruitment of 
microtubule-associated protein 1 light chain 3 (LC-3) 
on LD. LC-3 initiates formation of a limiting membrane 
though autophagy related protein 7 (Atg7)- dependent 
conjugation.64) It is reported that hepatic Atg7 
expression is decreased in ob/ob mice liver.65) Adipose-
speciﬁc knockout of Atg7 generated lean mice with 
reduced adipose mass, enhanced insulin sensitivity, and 
elevated rate of β-oxidation.66) While adipose-speciﬁc 
Atg7-deﬁcient mice show reduced WAT mass, BAT mass 
increases.66,67) The function of autophagy in regulating 
adipose physiology66,68) is quite diﬀerent from the role 
of autophagy in mobilizing lipids in other cell types69-71). 
Therefore, in WAT, autophagy may play a role in the 
induction of adipocyte diﬀerentiation and lipogenesis 
but not in lipolysis. In relationship between the 
cellular recycling process of autophagy and longevity, 
autophagy and lipase Lipl-4 function is requested to 
ensure prolonged life span in C. elegans.72) 
 Lysosomal lipase is called as “acid lipase” and thought 
to serve mainly in degradation of lipids contributed 
by the diet through endocytosis or those present in 
the membranes of organelles digested during the 
autophagic process. Lysosomal acid lipase (LAL, acid 
cholesteryl ester hydrolase) plays a role in intracellular 
hydrolysis of TG and cholesteryl esters. The released 
free cholesterol regulates endogenous synthesis of 
cholesterol, uptake of low density lipoprotein, and 
cholesterol esteriﬁcation. Deﬁciency of LAL occurs in 
two autosomal recessive storage disorders, cholesteryl 
ester storage disease (CESD) and Wolman disease. The 
LAL gene expression is controlled by a transcription 
factor, forkhead homeobox type O1 (FoxO1). FoxO1 is 
a critical mediator both in the cellular stress pathway 
and in nutrient-regulated processes.73) FoxO1 up-
regulated under nutrient restriction modulates LAL gene 
expression in adipocytes74). FoxO1 also modulates lipid 
metabolism in adipose tissue by changing adipocyte size 




 ATGL, HSL, and MGL are crucial lipases in the 
degradation from TG to glycerol and fatty acids (Fig. 1). 
Moreover, the interaction between lipases and autophagy 
may be an essential factor of metabolism of fat. The 
productive control of lipases is accurately synchronized 
with cell signals such as cellular function, diﬀerentiation, 
proliferation, and cell death for the correspondence to 
environmental stress. The lipolysis always produces 
fatty acid, TG, and cholesterol to reduce the adipose size 
or LDs. Lipases are linked to cellular functions excluding 
lipid metabolism. It is important which pathway of 
















Fig1.   The mechanism of lipolysis by ATGL, HSL, and MG in adipose tissue
TG(tryacylglycerol) is hydrolyzed by 3 lipase into G(glycerol) and FA(fatty acid). ATGL is a ﬁrst rate-limiting enzyme of metabolism of 
TG. CGI-58 is a coactivator of ATGL. ATGL and CGI-58 are activated by perilipin A and lipolysis TG into DG and FA. G0S2 and TORC1 
signaling inhibit the lipolysis activity of ATGL. HSL is a second rate-limiting enzyme of lipolysis. HSL is phosohrylated by AMPK. And 
perilipin interacts with HSL and promotes lipolysis. MGL cleaves MG(monoacylglycerol) into G and FA.
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rather than the quantity of released fatty acid. In the 
future, main issues in lipid researches may not be to 
understand lipid metabolism just in energy homeoatasis 
but to understand the integration of cellular functions 
and energy homeostasis in its various patterns. 
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